Meet Stephanie Seremetis, Novo Nordisk CMO — Bio + How to Reach Out

Last updated: 2025-12-16

Who is Stephanie Seremetis?

Stephanie Seremetis is the CMO and CVP of Rare Disease at Novo Nordisk, with over 20 years of experience in pharmaceutical development, focusing on rare diseases, hemophilia, and women's health.

Stephanie Seremetis's Work History

She has a broad background in drug development, including strategic planning, regulatory strategy, and all stages of biopharmaceutical development. Stephanie has been with Novo Nordisk since 2018, leading efforts in rare diseases and biopharmaceuticals.

• 2018-01 - CMO and CVP, Rare Disease, Novo Nordisk
• 2016-08 - 2022-03 - CMO and CVP, Biopharmaceuticals, Novo Nordisk Inc
• 2012-05 - 2022-03 - CMO and CVP, Haemophilia R&D Portfolio, Novo Nordisk
• 2008-07 - 2012-05 - Vice President, Medical and Science Haemostasis, Novo Nordisk

Stephanie Seremetis's Education

Stephanie holds a Bachelor's degree in Neurobiology and Neurosciences from Cornell University and an MD from Stony Brook University. She also attended the Icahn School of Medicine at Mount Sinai.

• Cornell University - Bachelor's degree in Neurobiology and Neurosciences (1969 - 1974)
• Stony Brook University - MD (1974 - 1978)
• Icahn School of Medicine at Mount Sinai - Medical training

How to Reach Stephanie Seremetis?

You can reach Stephanie Seremetis at *******@novo nordisk.com or by calling +1 **********. To get Stephanie Seremetis's contact information and other B2B leads like this, sign up for a free account at Anybody.com.